Advertisement

Investigational New Drugs

, Volume 30, Issue 6, pp 2450–2450 | Cite as

Erratum to: Phase I clinical, pharmacokinetic, and pharmacodynamic study of KOS-862 (Epothilone D) in patients with advanced solid tumors and lymphoma

  • Jason Konner
  • Rachel N. Grisham
  • Jae Park
  • Owen A. O’Connor
  • Gillian Cropp
  • Robert Johnson
  • Alison L. Hannah
  • Martee L. Hensley
  • Paul Sabbatini
  • Svetlana Mironov
  • Samuel Danishefsky
  • David Hyman
  • David R. Spriggs
  • Jakob Dupont
  • Carol Aghajanian
Erratum
  • 565 Downloads

Erratum to: Invest New Drugs

DOI 10.1007/s10637-011-9765-7

The surname of the author Svetlana Mironov, MD, was misspelled. The correct author’s surname should be “Mironov,” not “Miranov”.

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Jason Konner
    • 1
  • Rachel N. Grisham
    • 1
  • Jae Park
    • 1
  • Owen A. O’Connor
    • 2
  • Gillian Cropp
    • 3
  • Robert Johnson
    • 4
  • Alison L. Hannah
    • 3
  • Martee L. Hensley
    • 1
  • Paul Sabbatini
    • 1
  • Svetlana Mironov
    • 5
  • Samuel Danishefsky
    • 6
  • David Hyman
    • 1
  • David R. Spriggs
    • 1
  • Jakob Dupont
    • 7
  • Carol Aghajanian
    • 1
  1. 1.Gynecologic Medical Oncology Service, Department of MedicineMemorial Sloan-Kettering Cancer CenterNew YorkUSA
  2. 2.New York University Cancer InstituteNew YorkUSA
  3. 3.Nereus Pharmaceuticals, IncSan DiegoUSA
  4. 4.Aeolian BiomedLafayetteUSA
  5. 5.Department of RadiologyMemorial Sloan-Kettering Cancer CenterNew YorkUSA
  6. 6.Department of Molecular Pharmacology and ChemistryMemorial Sloan-Kettering Cancer CenterNew YorkUSA
  7. 7.Genentech, IncSouth San FranciscoUSA

Personalised recommendations